Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1953 4
1954 2
1956 1
1958 2
1960 5
1967 1
1968 3
1969 1
1970 4
1971 1
1977 1
1980 1
1983 1
1988 1
1991 2
1992 5
1994 3
1996 1
1999 1
2000 1
2001 1
2003 1
2005 1
2006 2
2007 1
2008 1
2009 4
2010 1
2011 3
2012 4
2013 5
2014 6
2015 6
2016 3
2017 3
2018 1
2021 2
2022 1
Text availability
Article attribute
Article type
Publication date

Search Results

81 results
Results by year
Filters applied: . Clear all
Page 1
Epigenetics meets immune checkpoints.
Covre A, Coral S, Di Giacomo AM, Taverna P, Azab M, Maio M. Covre A, et al. Among authors: taverna p. Semin Oncol. 2015 Jun;42(3):506-13. doi: 10.1053/j.seminoncol.2015.02.003. Epub 2015 Feb 14. Semin Oncol. 2015. PMID: 25965370 Review.
SGI-110: DNA Methyltransferase Inhibitor Oncolytic.
Griffiths EA, Choy G, Redkar S, Taverna P, Azab M, Karpf AR. Griffiths EA, et al. Among authors: taverna p. Drugs Future. 2013 Aug;38(8):535-543. Drugs Future. 2013. PMID: 26190889 Free PMC article.
2-Aminobenzimidazoles as potent Aurora kinase inhibitors.
Zhong M, Bui M, Shen W, Baskaran S, Allen DA, Elling RA, Flanagan WM, Fung AD, Hanan EJ, Harris SO, Heumann SA, Hoch U, Ivy SN, Jacobs JW, Lam S, Lee H, McDowell RS, Oslob JD, Purkey HE, Romanowski MJ, Silverman JA, Tangonan BT, Taverna P, Yang W, Yoburn JC, Yu CH, Zimmerman KM, O'Brien T, Lew W. Zhong M, et al. Among authors: taverna p. Bioorg Med Chem Lett. 2009 Sep 1;19(17):5158-61. doi: 10.1016/j.bmcl.2009.07.016. Epub 2009 Jul 9. Bioorg Med Chem Lett. 2009. PMID: 19646866
Epigenetic targeting of ovarian cancer stem cells.
Wang Y, Cardenas H, Fang F, Condello S, Taverna P, Segar M, Liu Y, Nephew KP, Matei D. Wang Y, et al. Among authors: taverna p. Cancer Res. 2014 Sep 1;74(17):4922-36. doi: 10.1158/0008-5472.CAN-14-1022. Epub 2014 Jul 17. Cancer Res. 2014. PMID: 25035395 Free PMC article.
Immunomodulatory Properties of DNA Hypomethylating Agents: Selecting the Optimal Epigenetic Partner for Cancer Immunotherapy.
Fazio C, Covre A, Cutaia O, Lofiego MF, Tunici P, Chiarucci C, Cannito S, Giacobini G, Lowder JN, Ferraldeschi R, Taverna P, Di Giacomo AM, Coral S, Maio M. Fazio C, et al. Among authors: taverna p. Front Pharmacol. 2018 Dec 7;9:1443. doi: 10.3389/fphar.2018.01443. eCollection 2018. Front Pharmacol. 2018. PMID: 30581389 Free PMC article.
Evaluation of vecabrutinib as a model for non-covalent BTK/ITK inhibition for treatment of chronic lymphocytic leukemia.
Jebaraj BMC, Müller A, Dheenadayalan RP, Endres S, Roessner PM, Seyfried F, Walliser C, Wist M, Qi J, Tausch E, Mertens D, Fox JA, Debatin KM, Meyer LH, Taverna P, Seiffert M, Gierschik P, Stilgenbauer S. Jebaraj BMC, et al. Among authors: taverna p. Blood. 2021 Oct 18:blood.2021011516. doi: 10.1182/blood.2021011516. Online ahead of print. Blood. 2021. PMID: 34662393
81 results